This topic contains a solution. Click here to go to the answer

Author Question: The design of modern X-ray telescopes depends on A) lenses made of germanium. B) the prime focus ... (Read 169 times)

Metfan725

  • Hero Member
  • *****
  • Posts: 552
The design of modern X-ray telescopes depends on
 
  A) lenses made of germanium.
  B) the prime focus design, with mirrors made of iron.
  C) grazing incidence optics.
  D) achromatic lenses to keep the X-rays in focus.
  E) the Cassegrain design, with mirrors made of lead.

Question 2

Which is brighter in our sky, a star with apparent magnitude 2 or a star with apparent magnitude 7? By how much is the star brighter?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

popopong

  • Sr. Member
  • ****
  • Posts: 307
Answer to Question 1

C

Answer to Question 2

A star with apparent magnitude 2 is 100 times brighter than a star with apparent magnitude 7. (Five magnitudes indicates a factor-of-100 difference; larger apparent magnitude stars are always fainter.)



Metfan725

  • Hero Member
  • *****
  • Posts: 552
Both answers were spot on, thank you once again




 

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library